Application of 3D QSAR and Docking Studies in Optimization of Perylene di imides as Anti Cancer Agent

2018 ◽  
Vol 52 (4) ◽  
pp. 666-675
Author(s):  
Catna Nagaraj Hemalatha ◽  
Vijey Aanandhi Muthkumar
Processes ◽  
2021 ◽  
Vol 9 (2) ◽  
pp. 329
Author(s):  
Yuko Tsuda ◽  
Koushi Hidaka ◽  
Keiko Hojo ◽  
Yoshio Okada

Plasmin (Plm), a trypsin-like serine protease, is responsible for fibrinolysis pathway and pathologic events, such as angiogenesis, tumor invasion, and metastasis, and alters the expression of cytokines. A growing body of data indicates that a Plm inhibitor is a potential candidate as an anti-inflammatory and anti-cancer agent. A class of active site-directed plasmin inhibitors containing tranexamic acid residue has been designed. As evidenced by docking studies, the inhibitor binds to the active site not to the lysine binding site (LBS) in plasmin, thus preventing plasmin from digesting the substrate. Further optimization of the series, concerning both activity and selectivity, led to the second generation of inhibitors. This review focuses on the Plm inhibitory activity-structure relationship of Plm inhibitors with the goal of realizing their design and clinical application.


2019 ◽  
Author(s):  
B Bhattarai ◽  
SK Steffensen ◽  
PL Gregersen ◽  
JH Jensen ◽  
KD Sørensen ◽  
...  
Keyword(s):  

2013 ◽  
Vol 20 (9) ◽  
pp. 1066-1078 ◽  
Author(s):  
Ritesh Agrawal ◽  
Pratima Jain ◽  
Subodh Dikshit ◽  
Sourabh Jain
Keyword(s):  
3D Qsar ◽  

2016 ◽  
Vol 19 (9) ◽  
pp. 735-751 ◽  
Author(s):  
Preeti Patel ◽  
Avineesh Singh ◽  
Vijay Patel ◽  
Deepak Jain ◽  
Ravichandran Veerasamy ◽  
...  

Author(s):  
Lalita Dahiya ◽  
Manoj Kumar Mahapatra ◽  
Ramandeep Kaur ◽  
Vipin Kumar ◽  
Manoj Kumar

Sign in / Sign up

Export Citation Format

Share Document